Substituted bicyclic cyclic derivative and use thereof

Details for Australian Patent Application No. 2007233035 (hide)

Owner Asahi Kasei Pharma Corporation Asahi Kasei Pharma Corporation

Inventors Matsumoto, Akiko; Shoda, Motoshi; Kuriyama, Hiroshi

Agent Watermark

Pub. Number AU-A-2007233035

PCT Pub. Number WO2007/114213

Priority 2006-095008 30.03.06 JP

Filing date 29 March 2007

Wipo publication date 11 October 2007

International Classifications

C07C 69/616 (2006.01) Esters of carboxylic acids

A61K 31/216 (2006.01)

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4184 (2006.01)

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/451 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/47 (2006.01) - Quinolines

A61K 31/472 (2006.01) - Non-condensed isoquinolines, e.g. papaverine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/5377 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 17/00 Drugs for dermatological disorders

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/114213 Priority application(s): WO2007/114213

8 January 2009 Amendment Made

  The nature of the amendment is: Amend the invention title to read Substituted bicyclic derivative and use thereof 2007235322 WOODLAND BIOFUELS INC. The nature of the amendment is as shown in the statement(s) filed 05 Nov 2008

8 January 2009 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Asahi Kasei Pharma Corporation and Asahi Kasei Pharma Corporation, Application No. 2007233035, under INID (71), remove the co-applicant Asahi Kasei Pharma Corporation

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007233041-Preparation of chiral amides and amines

2007233022-Hydrocracking catalyst and process for producing fuel substrate